Barclays raises target for Croda stock from GBp 3,400.00 to GBp 3,500.00

Published on 10/06/2026 at 15:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

H1 sales rose 5.00 percent to GBP 881.0 million. Croda stock costs EUR 39.93 on October 6, 2026 after EUR 39.24.

Pop-Art-Comic mit lachendem Chemiker und bunt sprudelnden Reagenzgläsern im Labor — Croda International Plc (ISIN GB00BJFFLV09) wird augenzwinkernd als Pop-Art-Comic mit Chemiker und bunten Reagenzgläsern gezeigt, Illustration mit AI erstellt.

Croda International (ISIN GB00BJFFLV09) was trading at EUR 39.93 at Lang & Schwarz on October 6, 2026 at 3:20 p.m. CEST, up 1.76 percent versus the prior close of EUR 39.24. On September 28, 2026, TradingView reported that Barclays raised its Croda price target from GBp 3,400.00 to GBp 3,500.00 and kept an Overweight recommendation.

Barclays lifts the target

The target increase gives the latest analyst signal a concrete level. The new GBp 3,500.00 target sits above the primary-exchange price of GBp 3,372.00 supplied for Croda on October 6, 2026, while the target change itself was GBp 100.00, or 2.94 percent, above Barclays' earlier GBp 3,400.00 level.

The broader analyst picture is also constructive. Investing.com listed 13 analysts with an average 12-month target of GBp 3,696.20, including 9 Buy and 4 Hold ratings, based on its September 2026 survey.

H1 profit outpaced sales

For the first half of fiscal 2026, Croda delivered the operating pattern management highlighted: sales increased 5.00 percent to GBP 881.0 million, while adjusted operating profit rose 7.00 percent to GBP 156.0 million. Adjusted earnings per share increased 9.00 percent to GBP 0.78, and the adjusted operating margin moved from 17.20 percent to 17.70 percent.

Yahoo Finance reported the first-half figures on September 19, 2026 and said Croda retained its 2026 outlook for organic sales growth of 3.00 percent to 6.00 percent, alongside further adjusted-margin improvement. Free cash flow reached GBP 38.0 million, compared with GBP 28.0 million in the first half of 2025, and the interim dividend was GBP 0.48 per share.

Stock gains in London

Croda develops specialty ingredients for consumer care, agriculture and pharmaceutical products, according to Croda. Its first-half result therefore matters most through the combination of sales growth, profit conversion and margin expansion rather than revenue growth alone.

On the London Stock Exchange, the primary-exchange quote was GBp 3,372.00 on October 6, 2026, with a 52-week range of GBp 2,488.00 to GBp 3,520.24. The Lang & Schwarz quote was EUR 39.93 in trading on October 6, 2026 at 3:20 p.m. CEST, plus 1.76 percent versus the Lang & Schwarz prior close of EUR 39.24 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Croda stock.